These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 38449060)
21. EAE Induction by Passive Transfer of MOG-specific CD4 Tanaka Y; Arima Y; Higuchi K; Ohki T; Elfeky M; Ota M; Kamimura D; Murakami M Bio Protoc; 2017 Jul; 7(13):e2370. PubMed ID: 34541112 [TBL] [Abstract][Full Text] [Related]
22. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Arima Y; Harada M; Kamimura D; Park JH; Kawano F; Yull FE; Kawamoto T; Iwakura Y; Betz UA; Márquez G; Blackwell TS; Ohira Y; Hirano T; Murakami M Cell; 2012 Feb; 148(3):447-57. PubMed ID: 22304915 [TBL] [Abstract][Full Text] [Related]
23. Depletion of Retinal Dopaminergic Activity in a Mouse Model of Rod Dysfunction Exacerbates Experimental Autoimmune Uveoretinitis: A Role for the Gateway Reflex. Stofkova A; Zloh M; Andreanska D; Fiserova I; Kubovciak J; Hejda J; Kutilek P; Murakami M Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008877 [TBL] [Abstract][Full Text] [Related]
25. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke. Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183 [TBL] [Abstract][Full Text] [Related]
26. Regulation of immune cell infiltration into the CNS by regional neural inputs explained by the gate theory. Arima Y; Kamimura D; Sabharwal L; Yamada M; Bando H; Ogura H; Atsumi T; Murakami M Mediators Inflamm; 2013; 2013():898165. PubMed ID: 23990699 [TBL] [Abstract][Full Text] [Related]
27. The pathological and physiological roles of IL-6 amplifier activation. Murakami M; Hirano T Int J Biol Sci; 2012; 8(9):1267-80. PubMed ID: 23136555 [TBL] [Abstract][Full Text] [Related]
28. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption. Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807 [TBL] [Abstract][Full Text] [Related]
29. Central Nervous System Barriers Impact Distribution and Expression of iNOS and Arginase-1 in Infiltrating Macrophages During Neuroinflammation. Ivan DC; Walthert S; Locatelli G Front Immunol; 2021; 12():666961. PubMed ID: 33936108 [TBL] [Abstract][Full Text] [Related]
30. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum. Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917 [TBL] [Abstract][Full Text] [Related]
31. The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology. Amoriello R; Memo C; Ballerini L; Ballerini C Mol Brain; 2024 Jan; 17(1):4. PubMed ID: 38263055 [TBL] [Abstract][Full Text] [Related]
32. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System. Samus M; Li YT; Sorokin L; Rottner K; Vestweber D J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms underlying lesion development and lesion distribution in CNS autoimmunity. Lindner M; Klotz L; Wiendl H J Neurochem; 2018 Jul; 146(2):122-132. PubMed ID: 29574788 [TBL] [Abstract][Full Text] [Related]
34. The clinical features and potential mechanisms of cognitive disorders in peripheral autoimmune and inflammatory diseases. Fan KQ; Huang T; Yu JS; Li YY; Jin J Fundam Res; 2024 Mar; 4(2):226-236. PubMed ID: 38933510 [TBL] [Abstract][Full Text] [Related]
35. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Engelhardt B Curr Pharm Des; 2008; 14(16):1555-65. PubMed ID: 18673197 [TBL] [Abstract][Full Text] [Related]
36. Immune cell entry to central nervous system--current understanding and prospective therapeutic targets. Prendergast CT; Anderton SM Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):315-27. PubMed ID: 20028334 [TBL] [Abstract][Full Text] [Related]
37. Regulation of immune cell entry into the central nervous system. Engelhardt B Results Probl Cell Differ; 2006; 43():259-80. PubMed ID: 17068976 [TBL] [Abstract][Full Text] [Related]
38. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Jadidi-Niaragh F; Mirshafiey A Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381 [TBL] [Abstract][Full Text] [Related]
39. A four-step model for the IL-6 amplifier, a regulator of chronic inflammations in tissue-specific MHC class II-associated autoimmune diseases. Murakami M; Hirano T Front Immunol; 2011; 2():22. PubMed ID: 22566812 [TBL] [Abstract][Full Text] [Related]
40. Brain micro-inflammation at specific vessels dysregulates organ-homeostasis via the activation of a new neural circuit. Arima Y; Ohki T; Nishikawa N; Higuchi K; Ota M; Tanaka Y; Nio-Kobayashi J; Elfeky M; Sakai R; Mori Y; Kawamoto T; Stofkova A; Sakashita Y; Morimoto Y; Kuwatani M; Iwanaga T; Yoshioka Y; Sakamoto N; Yoshimura A; Takiguchi M; Sakoda S; Prinz M; Kamimura D; Murakami M Elife; 2017 Aug; 6():. PubMed ID: 28809157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]